SCHEMBL25970326

SCHEMBL25970326

CCCCN(C)Cc1ccccc1-c1ccc2c(c1)CC(=O)N2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA1 P42261 2/20 0.59
CACNG8 Q8WXS5 2/20 0.59
BRD4 O60885 2/20 0.45
CREBBP Q92793 1/20 0.45
PGR P06401 4/20 0.43
ALOX5AP P20292 1/20 0.42
FEN1 P39748 1/20 0.42
PDE3B Q13370 1/20 0.42
PDE3A Q14432 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
CRBN Q96SW2 1/20 0.39
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
KMT2A Q03164 1/20 0.38
CDC7 O00311 1/20 0.38
CCNE1 P24864 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24192731 0.86 GRIA1 (0.55) GRIA1CACNG8BRD4CREBBPPGR
SCHEMBL21483771 0.78 GRIA1 (0.66) GRIA1CACNG8BRD4CREBBPPGR
SCHEMBL10714302 0.75 GRIA1 (1.00) GRIA1CACNG8BRD4CREBBPPGR
SCHEMBL25977402 0.75 GRIA1 (0.45) GRIA1CACNG8BRD4CREBBPPGR
SCHEMBL25970414 0.74 GRIA1 (0.45) GRIA1CACNG8BRD4CREBBPPGR
SCHEMBL25970325 0.73 GRIA1 (0.46) GRIA1CACNG8BRD4PGRPDE3B
SCHEMBL4481831 0.71 PDE3B (0.56) GRIA1CACNG8BRD4CREBBPPGR
SCHEMBL10712809 0.70 GRIA1 (0.69) GRIA1CACNG8BRD4CREBBPPGR
SCHEMBL28639586 0.70 GRIA1 (0.69) GRIA1CACNG8BRD4CREBBPPGR
SCHEMBL24884440 0.70 GRIA1 (0.69) GRIA1CACNG8BRD4CREBBPPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257396-A1 MACROCYCLES AND THEIR USE BLOSSOMHILL THERAPEUTICS INC (US) 2023-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257396-A1 MACROCYCLES AND THEIR USE VHL, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, DLD GRIA1 4738/4885CACNG8 1780/4885BRD4 667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.